Michael A. Metzger, Director at CTI BIOPHARMA CORP (CTIC), sold 179,669 shares at $6.14 ($1.1M) on 2022-07-05, disclosed to the SEC on 2022-07-07.
Open-market sale of $1.1M CTIC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.98 | 8,700 | $52K | 4.8% |
| 2 | $5.98 | 8,700 | $52K | 4.8% |
| 3 | $6.05 | 51,963 | $314K | 28.8% |
| 4 | $6.05 | 51,963 | $314K | 28.8% |
| 5 | $6.14 | 27,506 | $169K | 15.5% |
| 6 | $6.14 | 27,506 |
| $169K |
| 15.5% |
| 7 | $6.23 | 3,331 | $21K | 1.9% |
| Total | $6.07 avg | 179,669 | $1.1M | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |